Prevention hiv infections. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

CD4-Positive T-Lymphocytes CD8-Positive T-Lymphocytes Cells, Cultured Leukocytes, Mononuclear T-Lymphocytes Vagina

Organisms5

HIV-1 HIV HIV-2 Simian immunodeficiency virus Herpesvirus 2, Human

Diseases32

HIV Infections HIV Seropositivity Acquired Immunodeficiency Syndrome Substance Abuse, Intravenous AIDS-Related Opportunistic Infections Pregnancy Complications, Infectious AIDS Dementia Complex Sexually Transmitted Diseases Syphilis Coinfection Substance-Related Disorders AIDS-Related Complex HIV Wasting Syndrome Tuberculosis Sexually Transmitted Diseases, Viral Hepatitis C Disease Progression HIV Enteropathy Viremia Simian Acquired Immunodeficiency Syndrome Tuberculosis, Pulmonary Lymphoma, AIDS-Related AIDS-Associated Nephropathy Ulcer HIV-Associated Lipodystrophy Syndrome Mouth Diseases Acute Disease Hepatitis B Chronic Disease Sarcoma, Kaposi Herpes Genitalis Neoplasms

Chemicals and Drugs32

Anti-HIV Agents Anti-Retroviral Agents HIV Antigens HIV Protease Inhibitors HIV Core Protein p24 HIV Antibodies HIV Envelope Protein gp120 Receptors, HIV RNA, Viral Receptors, CCR5 Zidovudine HIV Reverse Transcriptase Antigens, CD4 Organophosphonates HIV Protease Crack Cocaine AIDS Vaccines Reverse Transcriptase Inhibitors Antitubercular Agents HIV Envelope Protein gp41 Antiviral Agents Adenine HIV Fusion Inhibitors Nevirapine Vaginal Creams, Foams, and Jellies Receptors, CXCR4 Biological Markers HIV Integrase Inhibitors tat Gene Products, Human Immunodeficiency Virus DNA, Viral Spermatocidal Agents Ritonavir

Analytical, Diagnostic and Therapeutic Techniques and Equipment58

HIV Seroprevalence AIDS Serodiagnosis CD4 Lymphocyte Count Risk Factors Prevalence Viral Load Antiretroviral Therapy, Highly Active Condoms Cross-Sectional Studies Incidence Cohort Studies Circumcision, Male Population Surveillance Mass Screening Questionnaires Prospective Studies Treatment Outcome Logistic Models Risk Assessment Program Evaluation Interviews as Topic Retrospective Studies Multivariate Analysis Follow-Up Studies Chemoprevention Case-Control Studies Longitudinal Studies Drug Therapy, Combination Contact Tracing Randomized Controlled Trials as Topic Administration, Intravaginal CD4-CD8 Ratio Odds Ratio Pilot Projects Clinical Trials as Topic Sentinel Surveillance Lymphocyte Activation Seroepidemiologic Studies Anonymous Testing Health Surveys Enzyme-Linked Immunosorbent Assay Risk Prenatal Care Vaginal Creams, Foams, and Jellies Data Collection Vaginal Douching Sensitivity and Specificity Early Diagnosis Double-Blind Method Delayed Diagnosis Regression Analysis Contraceptive Devices, Male Sampling Studies Intervention Studies Confidence Intervals Focus Groups Models, Theoretical Flow Cytometry

Psychiatry and Psychology26

Sexual Behavior Homosexuality, Male Risk-Taking Substance Abuse, Intravenous Prostitution Health Knowledge, Attitudes, Practice Unsafe Sex AIDS Dementia Complex Homosexuality Counseling Heterosexuality Safe Sex Substance-Related Disorders Risk Reduction Behavior Social Stigma Patient Compliance Attitude to Health Harm Reduction Stereotyping Health Behavior Medication Adherence Truth Disclosure Sexual Abstinence Transsexualism Sexuality Focus Groups

Phenomena and Processes17

HIV Seronegativity Homosexuality, Male CD4 Lymphocyte Count Viral Load Homosexuality Heterosexuality Pregnancy Time Factors Virus Replication Drug Resistance, Viral CD4-CD8 Ratio Odds Ratio Lymphocyte Activation Risk Sensitivity and Specificity Immunocompromised Host Sexuality

Disciplines and Occupations3

Public Health Qualitative Research Preventive Medicine

Anthropology, Education, Sociology and Social Phenomena15

Centers for Disease Control and Prevention (U.S.)Prostitution Health Education Socioeconomic Factors Needle Sharing Developing Countries Prisons Health Policy Age Distribution Demography United States Health Resources and Services Administration Truth Disclosure Emigration and Immigration Sex Distribution Rape

Information Science6

Prevalence Incidence Questionnaires Interviews as Topic Data Collection Focus Groups

Named Groups12

Sexual Partners Infant, Newborn Sex Workers HIV Long-Term Survivors Prisoners Drug Users African Americans Hispanic Americans Transients and Migrants Transgendered Persons Blood Donors Vulnerable Populations

Health Care82

HIV Seroprevalence Primary Prevention Risk Factors Prevalence Centers for Disease Control and Prevention (U.S.)Infectious Disease Transmission, Vertical Cross-Sectional Studies Health Knowledge, Attitudes, Practice Secondary Prevention Incidence Counseling Cohort Studies Population Surveillance Mass Screening Health Education Voluntary Programs Accident Prevention Questionnaires Epidemics Prospective Studies Socioeconomic Factors Rural Population Treatment Outcome Preventive Health Services Logistic Models Risk Assessment Program Evaluation Age Factors Patient Acceptance of Health Care Interviews as Topic Retrospective Studies Multivariate Analysis Health Promotion Public Health Follow-Up Studies Communicable Disease Control World Health Disease Transmission, Infectious Case-Control Studies Sex Factors Cost-Benefit Analysis Comorbidity Longitudinal Studies Patient Compliance Attitude to Health Contact Tracing Disease Outbreaks Randomized Controlled Trials as Topic Ambulatory Care Facilities Community Health Services Needle-Exchange Programs Health Policy Urban Health Age Distribution Urban Population Odds Ratio Demography Pilot Projects Clinical Trials as Topic Sentinel Surveillance Health Services Accessibility Seroepidemiologic Studies Anonymous Testing United States Health Resources and Services Administration Health Surveys Medication Adherence Risk Emigration and Immigration Sex Distribution Prenatal Care Rural Health Data Collection Sensitivity and Specificity Practice Guidelines as Topic Program Development Double-Blind Method Regression Analysis Sampling Studies Intervention Studies Confidence Intervals Focus Groups Women's Health

Geographicals35

South Africa United States Zimbabwe Uganda Africa South of the Sahara Malawi Zambia India Tanzania Kenya New York City Africa China Rwanda San Francisco Thailand Ethiopia Cameroon British Columbia Swaziland Puerto Rico Brazil Mozambique Namibia Nigeria Botswana Haiti Los Angeles Cote d'Ivoire Florida North Carolina London Lesotho Dominican Republic Baltimore

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

HIV Infections HIV Seropositivity HIV Seroprevalence HIV-1 Acquired Immunodeficiency Syndrome Anti-HIV Agents HIV Seronegativity AIDS Serodiagnosis Sexual Behavior HIV Homosexuality, Male Primary Prevention CD4 Lymphocyte Count Risk-Taking Risk Factors Anti-Retroviral Agents Prevalence Substance Abuse, Intravenous Centers for Disease Control and Prevention (U.S.)Viral Load Sexual Partners South Africa AIDS-Related Opportunistic Infections Antiretroviral Therapy, Highly Active United States Condoms Infectious Disease Transmission, Vertical HIV Antigens Prostitution Cross-Sectional Studies Zimbabwe CD4-Positive T-Lymphocytes Health Knowledge, Attitudes, Practice Unsafe Sex Pregnancy Complications, Infectious AIDS Dementia Complex Secondary Prevention HIV Protease Inhibitors Incidence Homosexuality Uganda HIV Core Protein p24 Counseling Cohort Studies Heterosexuality Sexually Transmitted Diseases Pregnancy Syphilis Africa South of the Sahara Circumcision, Male Safe Sex Malawi Population Surveillance HIV Antibodies Mass Screening HIV Envelope Protein gp120 Coinfection Substance-Related Disorders Health Education AIDS-Related Complex Voluntary Programs Risk Reduction Behavior Accident Prevention Questionnaires Epidemics Prospective Studies HIV Wasting Syndrome Time Factors Virus Replication Receptors, HIV RNA, Viral Receptors, CCR5 Infant, Newborn Zidovudine Tuberculosis Zambia Socioeconomic Factors Rural Population India Treatment Outcome Tanzania Preventive Health Services Logistic Models Sex Workers HIV-2 HIV Reverse Transcriptase HIV Long-Term Survivors Kenya Needle Sharing Risk Assessment Developing Countries Program Evaluation Sexually Transmitted Diseases, Viral Hepatitis C New York City Disease Progression Prisoners Age Factors Patient Acceptance of Health Care HIV Enteropathy

No FAQ available that match "prevention hiv infections"